|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400082746 |
|
最近更新日期: Date of Last Refreshed on: |
2024-04-07 12:00:17 |
|
注册时间: Date of Registration: |
2024-04-07 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
PPOS促排卵方案鲜胚移植的机制研究 |
|
Public title: |
Exploration of fresh embryo transfer in PPOS protocol |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
PPOS促排卵方案鲜胚移植的机制研究 |
|
Scientific title: |
Mechanism of fresh embryo transfer in PPOS protocol |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
王晓宁 |
研究负责人: |
张颖 |
|
Applicant: |
Xiaoning Wang |
Study leader: |
Ying Zhang |
|
申请注册联系人电话: Applicant telephone: |
+86 158 9785 2001 |
研究负责人电话: Study leader's telephone: |
+86 159 7187 7225 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
289636115@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
3981697@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
www.shiyanhospital.com/ |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
www.shiyanhospital.com/ |
|
申请注册联系人通讯地址: |
湖北省十堰市朝阳中路39号 |
研究负责人通讯地址: |
湖北省十堰市朝阳中路39号 |
|
Applicant address: |
Renmin Hospital,39 Chaoyang Zhong Lu, Shiyan City, Hubei Province |
Study leader's address: |
Renmin Hospital,39 Chaoyang Zhong Lu, Shiyan City, Hubei Province |
|
申请注册联系人邮政编码: Applicant postcode: |
442000 |
研究负责人邮政编码: Study leader's postcode: |
442000 |
|
申请人所在单位: |
十堰市人民医院生殖医学中心,湖北医药学院附属人民医院 |
||
|
Applicant's institution: |
Reproductive Medicine Center, Renmin Hospital, Hubei University of Medicine, Shiyan, People’s Republic of China |
||
|
研究负责人所在单位: |
十堰市人民医院生殖医学中心,湖北医药学院附属人民医院 |
||
|
Affiliation of the Leader: |
Reproductive Medicine Center, Renmin Hospital, Hubei University of Medicine, Shiyan, People’s Republic of China |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
syrmyy2022-019;SYSRMYY-034 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
十堰市人民医院医学伦理学委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Shiyan People's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-04-07 00:00:00 |
||
|
伦理委员会联系人: |
曹洪 |
||
|
Contact Name of the ethic committee: |
Hong Cao |
||
|
伦理委员会联系地址: |
湖北省十堰市朝阳中路39号 |
||
|
Contact Address of the ethic committee: |
Renmin Hospital,39 Chaoyang Zhong Lu, Shiyan City, Hubei Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 139 8691 6898 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
3981697@qq.com |
|
研究实施负责(组长)单位: |
十堰市人民医院生殖医学中心,湖北医药学院附属人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Reproductive Medicine Center, Renmin Hospital, Hubei University of Medicine, Shiyan, People’s Republic of China |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
湖北省十堰市朝阳中路39号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Renmin Hospital,39 Chaoyang Zhong Lu, Shiyan City, Hubei Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
Self support |
||||||||||||||||||||||
|
Target disease: |
Female infertility |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
单臂 |
||||||||||||||||||||||
|
Study design: |
Single arm |
||||||||||||||||||||||
|
研究目的: |
本研究拟招募20名自愿接受改良PPOS方案新鲜周期移植的患者,评估其助孕结局。如成功实施,该方案有望替代目前所有的促排卵方案,使每位患者的助孕费用大大降低,将惠及所有接受辅助生殖技术治疗的患者。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study aims to recruit 20 patients who voluntarily underwent fresh cycle transplantation with modified PPOS protocol and evaluate their assisted reproductive outcomes. If successfully implemented, this protocol is expected to replace all current ovarian stimulation protocols, which will greatly reduce the cost of pregnancy per patient and benefit all patients receiving assisted reproductive technology treatment. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
①女方年龄≤45岁,男方年龄≤50岁;②16kg/m2 ≤BMI≤35kg/m2;③采用我中心改良PPOS方案促排卵。 |
||||||||||||||||||||||
|
Inclusion criteria |
① Female age ≤45 years old, male age ≤50 years old; ②16kg/m2 ≤BMI≤35kg/m2; ③ Modified PPOS protocol was used for ovulation induction. |
||||||||||||||||||||||
|
排除标准: |
①子宫畸形(单角子宫、纵隔子宫、双角子宫等);②宫腔粘连;③取消促排卵周期或冻胚周期取消移植患者;④严重的全身性疾病如高血压、糖尿病及恶性肿瘤患者 |
||||||||||||||||||||||
|
Exclusion criteria: |
① Uterine malformation (unicornuate uterus, septate uterus, bicornuate uterus, etc.); ② intrauterine adhesions; ③ Cancelling ovulation induction cycle or freezing embryo cycle; ④ patients with serious systemic diseases such as hypertension, diabetes and malignant tumors |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-04-08 00:00:00至 To 2026-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2024-04-08 00:00:00 至 To 2026-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
由项目负责人秉承知情、自愿原则,在充分告知后,招募自愿者20人入组参与改良PPOS方案新鲜胚胎移植 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Based on the principle of informed and voluntary, 20 volunteers were recruited to participate in the modified PPOS protocol fresh embryo transfer |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
none |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
不共享 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
无 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
None |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |